- Q1 2024 Revolution Medicines Inc Earnings Call TranscriptMay 08, 2024$38.31 (-1.47%)Earnings
- Q4 2023 Revolution Medicines Inc Earnings Call TranscriptFeb 26, 2024$30.38 (+2.15%)Earnings
- Revolution Medicines Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Q3 2023 Revolution Medicines Inc Earnings Call TranscriptNov 06, 2023$21.54 (-2.80%)Earnings
- Revolution Medicines Inc To Discuss ESMO Data Presentation Call TranscriptOct 22, 2023
- Q2 2023 Revolution Medicines Inc Earnings Call TranscriptAug 08, 2023$30.17 (+1.79%)Earnings
- Revolution Medicines Inc To Acquire EQRx Inc Call TranscriptAug 01, 2023
- Revolution Medicines Inc at Barclays Lunchtime Biotech Fireside Chat Series TranscriptJun 15, 2023
- Revolution Medicines Inc at Goldman Sachs Healthcare Conference TranscriptJun 14, 2023
- Q1 2023 Revolution Medicines Inc Earnings Call TranscriptMay 08, 2023$24.44 (+0.41%)Earnings
- Revolution Medicines Inc at Needham Healthcare Conference (Virtual) TranscriptApr 20, 2023
- Q4 2022 Revolution Medicines Inc Earnings Call TranscriptFeb 27, 2023$24.37 (+0.16%)Earnings
- Revolution Medicines Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Revolution Medicines Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptDec 01, 2022
- Revolution Medicines Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 12, 2022
- Q2 2022 Revolution Medicines Inc Earnings Call TranscriptAug 09, 2022$23.76 (-2.62%)Earnings
- Revolution Medicines Inc Annual Shareholders Meeting TranscriptJun 16, 2022
- Revolution Medicines Inc at Guggenheim Partners Healthcare Talks Oncology Days (Virtual) TranscriptFeb 10, 2022
- Q2 2021 Revolution Medicines Inc Earnings Call TranscriptAug 11, 2021$26.9 (-0.81%)Earnings
- Revolution Medicines Inc at H C Wainwright Global Life Sciences Conference (Virtual) TranscriptMar 09, 2021
- Revolution Medicines Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 03, 2021
- Revolution Medicines Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
Q2 2023 Revolution Medicines Inc Earnings Call Transcript
Good day, and thank you for standing by. Welcome to Revolution Medicines' Second Quarter 2023 Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Erin Graves, Senior Director of Corporate Communications and Investor Relations. Please go ahead.
Thank you, and welcome, everyone, to the Second Quarter 2023 Earnings Call. Joining me on today's call are Dr. Mark Goldsmith, Revolution Medicines' Chairman and Chief Executive Officer; and Jack Anders, our Chief Financial Officer. Dr. Steve Kelsey, our President of R&D, will join us for the Q&A portion of today's call.
As we begin, I would like to note that our presentation will include statements regarding the current beliefs of Revolution Medicines with respect to our business and the proposed acquisition of EQRx, including statements regarding our development plans and time lines
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)